LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345...» Página 2 de 24 desde 01/07/1988 hasta 20/03/2018 25/10/2017 08:19 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others on business performance and financial information The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® Project in spanish Número de registro: 257753 24/10/2017 08:05 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others on business performance and financial information The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project. Número de registro: 257683 05/10/2017 09:39 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity contracts and specialists Liquidity contract: transactions conducted from 11 July to 30 September 2017 Número de registro: 257047 Rectificado por 256992 del 03/10/2017 (13:53) 03/10/2017 13:53 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity contracts and specialists Liquidity contract: transactions conducted from 11 July to 30 September 2017 Número de registro: 256992 Rectificado por 257047 del 05/10/2017 (09:39) 07/09/2017 17:45 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others on business performance and financial information The Company informs that commences the enoxaparin biosimilar marketing in Germany Número de registro: 256121 26/07/2017 07:52 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on P&L The Company releases the presentation related to the First Half of 2017 financial results Número de registro: 254996 26/07/2017 07:46 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on P&L The Company releases the press release related to the First Half 2017 financial results Número de registro: 254993 26/07/2017 07:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2017 Número de registro: 254990 25/07/2017 18:06 LABORATORIOS FARMACEUTICOS ROVI, S.A. Others about corporate governance La Sociedad informa sobre la modificación de su Reglamento Interno de Conducta en los Mercados de Valores. Número de registro: 254952 10/07/2017 19:20 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity contracts and specialists The Company informs that has subscribed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Número de registro: 254434 Relacionado con 270230 del 04/10/2018 (23:13) Página 2 de 24 «12345...»